EspeRare and Pierre Fabre present their pioneering prenatal treatment, ER004 in XLHED, the EDELIFE clinical trial, at the 8th International Conference on Ectodermal Dysplasias (ICED) in Paris, 9-11 June 2022. Professor Holm Schneider from the University of Erlangen, Germany, coordinating investigator of the EDELIFE trial, will discuss future perspectives in ED, keeping a patient focus.
The conference gathers medical professionals, research scientists, representatives of patient organisations and business actors with a goal to share knowledge and experience around this rare disease.
For more information on the ICED 2022, please visit: Home ICED 2022.
